Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NovoCure Ltd Director's Dealing 2018

Apr 30, 2018

31949_dirs_2018-04-30_f9b9d416-be95-4b59-866a-786e2bb1d855.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Novocure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2018-04-26

Reporting Person: Palti Yoram (Director, Chief Technology Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-04-26 Ordinary Shares S 6200 $25.52 Disposed 1175820 Indirect
2018-04-26 Ordinary Shares S 14766 $26.33 Disposed 1161054 Indirect

Footnotes

F1: On April 26, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 6,200 shares in multiple trades at prices ranging from $25.00 to $25.95. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F2: Professor Palti shares voting and investment power for the shares held by Bennett Limited.

F3: On April 26, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 14,766 shares in multiple trades at prices ranging from $26.00 to $26.75. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.